ZHAO Xiang-yu, WANG Yao, WANG Gui-bin, ZHANG Jian-jun. Disruption of iron homeostasis and relevant pharmacotherapies in Alzheimer's diseaseJ. Acta Pharmaceutica Sinica, 2016,51(6): 866-872. doi: 10.16438/j.0513-4870.2016-0220
Citation: ZHAO Xiang-yu, WANG Yao, WANG Gui-bin, ZHANG Jian-jun. Disruption of iron homeostasis and relevant pharmacotherapies in Alzheimer's diseaseJ. Acta Pharmaceutica Sinica, 2016,51(6): 866-872. doi: 10.16438/j.0513-4870.2016-0220

Disruption of iron homeostasis and relevant pharmacotherapies in Alzheimer's disease

  • Iron is the most abundant metal element to support the body's physiological activities and play crucial roles in the central nervous system. Iron homeostasis is under strict control in normal circumstances, and some diseases will occur once the homeostasis was disrupted. Numerous researches suggest that iron homeostasis disruptes in Alzheimer's disease (AD) and the homeostasis disruption interacts with AD's hallmarks. Dispute still exists on how iron plays a role in AD despite of the great number of researches. This article will focus on iron metabolism, normal function in the brain and recent therapies of AD based on iron chelation.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return